Novocure Ltd (NVCR)
Healthcare
Medical Devices
14.80 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Novocure Ltd (NVCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.2% of the shares are freely tradable; institutional investors hold 88.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
88.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
10.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
82.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
11.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
116Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.74 | 17,069,149 | +1.6 | 03/31/2026 |
| BlackRock Inc | 11.39 | 13,193,765 | -2.6 | 03/31/2026 |
| Vanguard Group Inc | 9.46 | 10,958,209 | +4.8 | 12/31/2025 |
| Soleus Capital Management, L.P. | 9.06 | 10,492,391 | +23.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.40 | 6,251,701 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.04 | 4,682,064 | +0.0 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 3.92 | 4,541,526 | -10.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 7.04 | 8,149,028 | +0.1 | 04/30/2026 |
| Fidelity Growth Company Fund | 5.05 | 5,853,257 | +5.7 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.95 | 3,421,259 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.